Edesa Biotech Reports Positive Interim Results in Dermatitis Trial
Go back to Edesa Biotech Reports Positive Interim Results in Dermatitis Trial| (NASDAQ: EDSA) | Delayed: 5.75 +0.04 (0.70%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.71 | 52 Week High | $ | |||
| Open | $5.71 | 52 Week Low | $ | |||
| Day High | $6.00 | P/E | N/A | |||
| Day Low | $5.61 | EPS | $ | |||
| Volume | 110,394 | |||||
